Open Access663 Onset of Response With Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease
Author(s) -
Chris Fourment,
Timothy E. Ritter,
Samantha A. Kuten,
Thomas C. Hardin,
Lucinda J. Van Anglen
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592188.53944.83
Subject(s) - vedolizumab , medicine , infliximab , ulcerative colitis , inflammatory bowel disease , gastroenterology , demographics , crohn's disease , cohort , surgery , disease , demography , sociology